This study evaluates the function of C1 inhibitor (fC1INH) in patients with suspected HAE using several laboratory methods: dried blood spot (DBS), chromogenic assay, and ELISA with FXIIa and PKa (plasma kallikrein). This evidence concerns the gene KLK4 and hereditary angioedema.